Title : Tumor specific activation of PKR as a non-toxic modality of cancer treatment.

Pub. Date : 2003 Aug

PMID : 14563126






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Small molecules, mainly tyrosine kinase inhibitors (tyrphostins) like Gleevec, Iressa targeting CML and EGFR overexpressing tumors have entered the clinic, where a large number of other tyrphostins are at various stages of clinical development. Tyrphostins epidermal growth factor receptor Homo sapiens
2 Small molecules, mainly tyrosine kinase inhibitors (tyrphostins) like Gleevec, Iressa targeting CML and EGFR overexpressing tumors have entered the clinic, where a large number of other tyrphostins are at various stages of clinical development. Tyrphostins epidermal growth factor receptor Homo sapiens